KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenet Healthcare (THC) Acquisitions (2016 - 2025)

Tenet Healthcare's Acquisitions history spans 16 years, with the latest figure at $42.0 million for Q4 2025.

  • For Q4 2025, Acquisitions fell 10.64% year-over-year to $42.0 million; the TTM value through Dec 2025 reached $308.0 million, down 46.06%, while the annual FY2025 figure was $308.0 million, 46.06% down from the prior year.
  • Acquisitions for Q4 2025 was $42.0 million at Tenet Healthcare, down from $119.0 million in the prior quarter.
  • Across five years, Acquisitions topped out at $1.2 billion in Q4 2021 and bottomed at $10.0 million in Q4 2022.
  • The 5-year median for Acquisitions is $47.0 million (2024), against an average of $134.6 million.
  • The largest annual shift saw Acquisitions surged 3800.0% in 2021 before it tumbled 99.13% in 2022.
  • A 5-year view of Acquisitions shows it stood at $1.2 billion in 2021, then crashed by 99.13% to $10.0 million in 2022, then skyrocketed by 1040.0% to $114.0 million in 2023, then plummeted by 58.77% to $47.0 million in 2024, then fell by 10.64% to $42.0 million in 2025.
  • Per Business Quant, the three most recent readings for THC's Acquisitions are $42.0 million (Q4 2025), $119.0 million (Q3 2025), and $120.0 million (Q2 2025).